CD4 + CD25high Regulatory T Cell Numbers and FOXP3 mRNA Expression in Patients with Advanced Esophageal Cancer Before and After Chemotherapy

[1]  S. Xiong,et al.  Does chemotherapy augment anti-tumor immunotherapy by preferential impairment of regulatory T cells? , 2008, Medical hypotheses.

[2]  F. Powrie,et al.  Emerging Challenges in Regulatory T Cell Function and Biology , 2007, Science.

[3]  S. Ziegler,et al.  Foxp3 Is Required Throughout the Life of a Regulatory T Cell , 2007, Science's STKE.

[4]  Jing Xian Lee,et al.  Intra-tumoural regulatory T cells: a potential new target in cancer immunotherapy. , 2006, Biochemical and biophysical research communications.

[5]  S. Takashima,et al.  CD4+CD25+ regulatory T cells in the peripheral blood of patients with breast cancer and non-small cell lung cancer. , 2005, Oncology reports.

[6]  H. Cantor,et al.  Regulatory T cells and autoimmune disease , 2005, Immunological reviews.

[7]  J. Berzofsky,et al.  Immunoregulatory T cells in tumor immunity. , 2004, Current opinion in immunology.

[8]  B. Bienvenu,et al.  Suppression of CD4+ T Lymphocyte Effector Functions by CD4+CD25+ Cells In Vivo1 , 2004, The Journal of Immunology.

[9]  H. Fujii,et al.  Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[10]  T. Sasada,et al.  CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies , 2003, Cancer.

[11]  M. Steurer,et al.  Increase of regulatory T cells in the peripheral blood of cancer patients. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[12]  T. Nomura,et al.  Control of Regulatory T Cell Development by the Transcription Factor Foxp3 , 2002 .

[13]  S. Sakaguchi,et al.  The role of regulatory T cells in controlling immunologic self-tolerance. , 2003, International review of cytology.